ERBB2 and neoplasm: The DMFS by tumor subtype was 95.8%, 88.2, and 94.4% for LUM, TNBC, and HER2+, and the DMFS by surgical procedure was 95.7% for BCS and 92.1% for conservative mastectomy (Figure 2).